The Medical Research Council's treatment trial for mild hypertension was designed to determine the effects of blood pressure reduction on cardiovascular morbidity and mortality rather than to compare the separate effects of thiazides and beta-adrenergic blocking agents. However, the simultaneous use of both active treatments was discouraged and comparisons in terms of blood pressure control, adverse drug reactions, and drug-related changes in the serum biochemistry are possible. The net differences in systolic and diastolic pressure between treated and control subjects were greater in older than in younger people; this net difference was more pronounced in the older people assigned at random to receive bendrofluazide as opposed to propranolol; this effect increased with time during the trial. The need for a supplementary drug (methyldopa) to control blood pressure at target level, was greater in the thiazide-treated group for all ages. Withdrawal from randomized treatment due to adverse reactions was greater in men receiving bendrofluazide than in those receiving propranolol, and greater for women receiving propranolol than in those receiving bendrofluazide. Thiazide treatment was shown, in a sub-study, to be associated with a ...Continue Reading
Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring
A randomized, placebo-controlled study of loop diuretics in patients with essential hypertension: the bumetanide and furosemide on lipid profile (BUFUL) clinical study report
Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension?
New insights and approaches to reduce end-organ damage in the treatment of hypertension: subsets of hypertension approach
New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension
The impact of thiazide diuretics on the initiation of lipid-reducing agents in older people: a population-based analysis
The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension
Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis
Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
The effects of omega-3 polyunsaturated fatty acids on blood pressure: a methodologic analysis of the evidence
Should thiazide diuretics be given as first line antihypertensive therapy or in addition to other medications?
Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?
Angiotensin converting enzyme inhibition. Unique and effective therapy for hypertension and congestive heart failure
Antihypertensive Agents: Mechanisms of Action
Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.